title: Implications of "not me" drugs for health systems: lessons from age related macular degeneration.
authors.affiliation: Department of Ophthalmology, Hotel Dieu Hospital and Queen's University, 166 Brock Street, Kingston, Ontario, Canada K7L 5G2. rob.campbell@queensu.ca
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Campbell
authors.forename: Irfan A
authors.initials: IA
authors.lastname: Dhalla
authors.forename: Sudeep S
authors.initials: SS
authors.lastname: Gill
authors.forename: Chaim M
authors.initials: CM
authors.lastname: Bell
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000627:therapeutic use*; D000068258:Bevacizumab; D017277:Drug Approval; D004345:Drug Industry / Q000191:economics; D005378:Financial Support; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000191:economics; D000069579:Ranibizumab
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab